Risk stratification for hospital-acquired venous thromboembolism in medical patients (RISE): Protocol for a prospective cohort study
- PMID: 35609087
- PMCID: PMC9128957
- DOI: 10.1371/journal.pone.0268833
Risk stratification for hospital-acquired venous thromboembolism in medical patients (RISE): Protocol for a prospective cohort study
Abstract
Background: Hospital-acquired venous thromboembolism (VTE) is one of the leading preventable causes of in-hospital mortality. However, its risk assessment in medically ill inpatients is complicated due to the patients' heterogeneity and complexity of currently available risk assessment models (RAMs). The simplified Geneva score provides simplicity but has not yet been prospectively validated. Immobility is an important predictor for VTE in RAMs, but its definition is inconsistent and based on subjective assessment by nurses or physicians. In this study, we aim to prospectively validate the simplified Geneva score and to examine the predictive performance of a novel and objective definition of in-hospital immobilization using accelerometry.
Methods and analysis: RISE is a multicenter prospective cohort study. The goal is to recruit 1350 adult inpatients admitted for medical illness in three Swiss tertiary care hospitals. We collect data on demographics, comorbidities, VTE risk and thromboprophylaxis. Mobility from admission to discharge is objectively measured using a wrist-worn accelerometer. Participants are followed for 90 days for the occurrence of symptomatic VTE (primary outcome). Secondary outcomes are the occurrence of clinically relevant bleeding, and mortality. The evolution of autonomy in the activities of daily living, the length of stay, and the occurrence of readmission are also recorded. Time-dependent area under the curve, sensitivity, specificity, and positive and negative predictive values are calculated for each RAM (i.e. the simplified and original Geneva score, Padua, and IMPROVE score) with and without the objective mobility measures to assess their accuracy in predicting hospital-acquired VTE at 90 days.
Ethics and expected impact: The ethics committee approved the protocol and the study was registered on ClinicalTrials.gov as NCT04439383. RISE has the potential to optimize VTE risk stratification, and thus to improve the quality of care of medically hospitalized patients.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Risk Assessment Models for Venous Thromboembolism in Medical Inpatients.JAMA Netw Open. 2024 May 1;7(5):e249980. doi: 10.1001/jamanetworkopen.2024.9980. JAMA Netw Open. 2024. PMID: 38728035 Free PMC article.
-
Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients.Thromb Haemost. 2018 Jan;118(1):82-89. doi: 10.1160/TH17-06-0403. Epub 2018 Jan 5. Thromb Haemost. 2018. PMID: 29304528
-
External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort.J Thromb Haemost. 2020 Mar;18(3):676-680. doi: 10.1111/jth.14688. Epub 2019 Dec 16. J Thromb Haemost. 2020. PMID: 31782886
-
Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review.BMJ Open. 2021 Jul 29;11(7):e045672. doi: 10.1136/bmjopen-2020-045672. BMJ Open. 2021. PMID: 34326045 Free PMC article.
-
Updated clinical models for VTE prediction in hospitalized medical patients.Thromb Res. 2018 Apr;164 Suppl 1:S62-S69. doi: 10.1016/j.thromres.2018.02.004. Thromb Res. 2018. PMID: 29703486 Review.
Cited by
-
In-Hospital versus Out-of-Hospital Pulmonary Embolism: Clinical Characteristics, Biochemical Markers and Echocardiographic Indices.J Cardiovasc Dev Dis. 2024 Mar 28;11(4):103. doi: 10.3390/jcdd11040103. J Cardiovasc Dev Dis. 2024. PMID: 38667721 Free PMC article.
-
Usefulness of Myocardial Injury Parameters in Predicting Prolonged Postoperative Use of Inotropes Drugs in Patients Undergoing Heart Valve Surgery.J Clin Med. 2025 Apr 15;14(8):2719. doi: 10.3390/jcm14082719. J Clin Med. 2025. PMID: 40283552 Free PMC article.
-
The Benefits and Imperative of Venous Thromboembolism Risk Screening for Hospitalized Patients: A Systematic Review.J Clin Med. 2023 Nov 9;12(22):7009. doi: 10.3390/jcm12227009. J Clin Med. 2023. PMID: 38002623 Free PMC article. Review.
-
Overuse and underuse of thromboprophylaxis in medical inpatients.Res Pract Thromb Haemost. 2023 Aug 23;7(6):102184. doi: 10.1016/j.rpth.2023.102184. eCollection 2023 Aug. Res Pract Thromb Haemost. 2023. PMID: 37745158 Free PMC article.
-
Risk Assessment Models for Venous Thromboembolism in Medical Inpatients.JAMA Netw Open. 2024 May 1;7(5):e249980. doi: 10.1001/jamanetworkopen.2024.9980. JAMA Netw Open. 2024. PMID: 38728035 Free PMC article.
References
-
- Maynard G. Preventing hospital-associated venous thromboembolism: a guide for effective quality improvement. 2nd ed Rockville, MD: Agency for Healthcare Research and Quality, August 2016. AHRQ Publication No 16-0001-EF; accessed at: https://wwwahrqgov/sites/default/files/publications/files/vteguidepdf July 15, 2019.
-
- Alikhan R, Bedenis R, Cohen AT. Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction). Cochrane Database Syst Rev. 2014;(5):CD003747. Epub 2014/05/09. doi: 10.1002/14651858.CD003747.pub4 ; PubMed Central PMCID: PMC6491079. - DOI - PMC - PubMed